Trending Topic

4 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Respiratory & Pulmonary Diseases. As we continually strive to deliver cutting-edge research and insightful commentary, this issue is no exception, featuring a diverse array of articles that illuminate both emerging treatments and evolving practices within the field of respiratory and pulmonary medicine. We begin with a compelling […]

Molla Imaduddin Ahmed, ERS 2021: Advances in the Treatment of Cystic Fibrosis

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 30th 2021

It was great to talk with Dr Molla Imaduddin Ahmed (Leicester Childrens’ Hospital, Leicester, UK) around the impact of CFTR modulator therapies and exciting advances in the treatment of cystic fibrosis.

Questions

  1. What has been the impact of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies on the treatment of cystic fibrosis (CF)? (0:20)
  2. What are the hot topics and latest research you are looking forward to exploring in cystic fibrosis during 2021? (1:36)

Disclosures: Molla Imaduddin Ahmed has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Victoria Jones.

Filmed as a highlight of ERS 2021 (Virtual).

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup